ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8B14826
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Orally Disintegrating Drug Market Research Report 2023
BUY CHAPTERS

Global Orally Disintegrating Drug Market Research Report 2025

Code: QYRE-Auto-8B14826
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson and Johnson
GSK
Otsuka
TEVA
Pfizer Inc
Eli Lilly and Company
Merck
Eisai Co Ltd
Astrazeneca plc
Bristol–Myers Squibb
Conquer
Vartris

Orally Disintegrating Drug Market Size

The global market for Orally Disintegrating Drug was valued at US$ 2336 million in the year 2024 and is projected to reach a revised size of US$ 4371 million by 2031, growing at a CAGR of 9.5% during the forecast period.

Orally Disintegrating Drug Market

Orally Disintegrating Drug Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The orally disintegrating drug market is being driven by several factors. One of the primary drivers is the growing demand for convenient and patient-friendly medication delivery methods. Orally disintegrating drugs offer an advantage over traditional oral tablets as they quickly dissolve in the mouth without the need for water, making them easier to administer, particularly for individuals with swallowing difficulties, pediatric patients, and the elderly. Additionally, the increasing prevalence of chronic diseases and the need for efficient and immediate drug absorption have fueled the demand for orally disintegrating drugs. Furthermore, advancements in formulation technologies and taste-masking techniques have improved the palatability of these drugs, enhancing patient compliance. Overall, the demand for orally disintegrating drugs is driven by the need for convenience, improved patient experience, and enhanced drug delivery options in the pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Drug.
The Orally Disintegrating Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Orally Disintegrating Drug Market Report

Report Metric Details
Report Name Orally Disintegrating Drug Market
Accounted market size in year US$ 2336 million
Forecasted market size in 2031 US$ 4371 million
CAGR 9.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Other
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson and Johnson, GSK, Otsuka, Vartris, Teva, Pfizer, Eli Lilly and Company, Merck, Eisai, AstraZeneca, Bristol-Myers Squibb, Conquer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Orally Disintegrating Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Orally Disintegrating Drug Market growing?

Ans: The Orally Disintegrating Drug Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the Orally Disintegrating Drug Market size in 2031?

Ans: The Orally Disintegrating Drug Market size in 2031 will be US$ 4371 million.

Who are the main players in the Orally Disintegrating Drug Market report?

Ans: The main players in the Orally Disintegrating Drug Market are Johnson and Johnson, GSK, Otsuka, Vartris, Teva, Pfizer, Eli Lilly and Company, Merck, Eisai, AstraZeneca, Bristol-Myers Squibb, Conquer

What are the Application segmentation covered in the Orally Disintegrating Drug Market report?

Ans: The Applications covered in the Orally Disintegrating Drug Market report are CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other

What are the Type segmentation covered in the Orally Disintegrating Drug Market report?

Ans: The Types covered in the Orally Disintegrating Drug Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Other

Recommended Reports

Oral Drug Delivery

Oral Tablet Technologies

Oral Disease Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orally Disintegrating Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Market by Application
1.3.1 Global Orally Disintegrating Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Orally Disintegrating Drug Market Perspective (2020-2031)
2.2 Global Orally Disintegrating Drug Growth Trends by Region
2.2.1 Global Orally Disintegrating Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Orally Disintegrating Drug Historic Market Size by Region (2020-2025)
2.2.3 Orally Disintegrating Drug Forecasted Market Size by Region (2026-2031)
2.3 Orally Disintegrating Drug Market Dynamics
2.3.1 Orally Disintegrating Drug Industry Trends
2.3.2 Orally Disintegrating Drug Market Drivers
2.3.3 Orally Disintegrating Drug Market Challenges
2.3.4 Orally Disintegrating Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orally Disintegrating Drug Players by Revenue
3.1.1 Global Top Orally Disintegrating Drug Players by Revenue (2020-2025)
3.1.2 Global Orally Disintegrating Drug Revenue Market Share by Players (2020-2025)
3.2 Global Orally Disintegrating Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Orally Disintegrating Drug Revenue
3.4 Global Orally Disintegrating Drug Market Concentration Ratio
3.4.1 Global Orally Disintegrating Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orally Disintegrating Drug Revenue in 2024
3.5 Global Key Players of Orally Disintegrating Drug Head office and Area Served
3.6 Global Key Players of Orally Disintegrating Drug, Product and Application
3.7 Global Key Players of Orally Disintegrating Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Orally Disintegrating Drug Breakdown Data by Type
4.1 Global Orally Disintegrating Drug Historic Market Size by Type (2020-2025)
4.2 Global Orally Disintegrating Drug Forecasted Market Size by Type (2026-2031)
5 Orally Disintegrating Drug Breakdown Data by Application
5.1 Global Orally Disintegrating Drug Historic Market Size by Application (2020-2025)
5.2 Global Orally Disintegrating Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Orally Disintegrating Drug Market Size (2020-2031)
6.2 North America Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Orally Disintegrating Drug Market Size by Country (2020-2025)
6.4 North America Orally Disintegrating Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Orally Disintegrating Drug Market Size (2020-2031)
7.2 Europe Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Orally Disintegrating Drug Market Size by Country (2020-2025)
7.4 Europe Orally Disintegrating Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Orally Disintegrating Drug Market Size (2020-2031)
8.2 Asia-Pacific Orally Disintegrating Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Orally Disintegrating Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Orally Disintegrating Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Orally Disintegrating Drug Market Size (2020-2031)
9.2 Latin America Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Orally Disintegrating Drug Market Size by Country (2020-2025)
9.4 Latin America Orally Disintegrating Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orally Disintegrating Drug Market Size (2020-2031)
10.2 Middle East & Africa Orally Disintegrating Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Orally Disintegrating Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Orally Disintegrating Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Orally Disintegrating Drug Introduction
11.1.4 Johnson and Johnson Revenue in Orally Disintegrating Drug Business (2020-2025)
11.1.5 Johnson and Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Orally Disintegrating Drug Introduction
11.2.4 GSK Revenue in Orally Disintegrating Drug Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Otsuka
11.3.1 Otsuka Company Details
11.3.2 Otsuka Business Overview
11.3.3 Otsuka Orally Disintegrating Drug Introduction
11.3.4 Otsuka Revenue in Orally Disintegrating Drug Business (2020-2025)
11.3.5 Otsuka Recent Development
11.4 Vartris
11.4.1 Vartris Company Details
11.4.2 Vartris Business Overview
11.4.3 Vartris Orally Disintegrating Drug Introduction
11.4.4 Vartris Revenue in Orally Disintegrating Drug Business (2020-2025)
11.4.5 Vartris Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Orally Disintegrating Drug Introduction
11.5.4 Teva Revenue in Orally Disintegrating Drug Business (2020-2025)
11.5.5 Teva Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Orally Disintegrating Drug Introduction
11.6.4 Pfizer Revenue in Orally Disintegrating Drug Business (2020-2025)
11.6.5 Pfizer Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Orally Disintegrating Drug Introduction
11.7.4 Eli Lilly and Company Revenue in Orally Disintegrating Drug Business (2020-2025)
11.7.5 Eli Lilly and Company Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Orally Disintegrating Drug Introduction
11.8.4 Merck Revenue in Orally Disintegrating Drug Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Eisai
11.9.1 Eisai Company Details
11.9.2 Eisai Business Overview
11.9.3 Eisai Orally Disintegrating Drug Introduction
11.9.4 Eisai Revenue in Orally Disintegrating Drug Business (2020-2025)
11.9.5 Eisai Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Orally Disintegrating Drug Introduction
11.10.4 AstraZeneca Revenue in Orally Disintegrating Drug Business (2020-2025)
11.10.5 AstraZeneca Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Orally Disintegrating Drug Introduction
11.11.4 Bristol-Myers Squibb Revenue in Orally Disintegrating Drug Business (2020-2025)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Conquer
11.12.1 Conquer Company Details
11.12.2 Conquer Business Overview
11.12.3 Conquer Orally Disintegrating Drug Introduction
11.12.4 Conquer Revenue in Orally Disintegrating Drug Business (2020-2025)
11.12.5 Conquer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson and Johnson
GSK
Otsuka
TEVA
Pfizer Inc
Eli Lilly and Company
Merck
Eisai Co Ltd
Astrazeneca plc
Bristol–Myers Squibb
Conquer
Vartris
List of Tables
 Table 1. Global Orally Disintegrating Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Anti-Psychotics Drug
 Table 3. Key Players of Anti-Epileptics Drug
 Table 4. Key Players of Other
 Table 5. Global Orally Disintegrating Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Orally Disintegrating Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Orally Disintegrating Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Orally Disintegrating Drug Market Share by Region (2020-2025)
 Table 9. Global Orally Disintegrating Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Orally Disintegrating Drug Market Share by Region (2026-2031)
 Table 11. Orally Disintegrating Drug Market Trends
 Table 12. Orally Disintegrating Drug Market Drivers
 Table 13. Orally Disintegrating Drug Market Challenges
 Table 14. Orally Disintegrating Drug Market Restraints
 Table 15. Global Orally Disintegrating Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Orally Disintegrating Drug Market Share by Players (2020-2025)
 Table 17. Global Top Orally Disintegrating Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Drug as of 2024)
 Table 18. Ranking of Global Top Orally Disintegrating Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Orally Disintegrating Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Orally Disintegrating Drug, Headquarters and Area Served
 Table 21. Global Key Players of Orally Disintegrating Drug, Product and Application
 Table 22. Global Key Players of Orally Disintegrating Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Orally Disintegrating Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Orally Disintegrating Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Orally Disintegrating Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Orally Disintegrating Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Orally Disintegrating Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Orally Disintegrating Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Orally Disintegrating Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Orally Disintegrating Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Orally Disintegrating Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Orally Disintegrating Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Orally Disintegrating Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Orally Disintegrating Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Orally Disintegrating Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Orally Disintegrating Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Johnson and Johnson Company Details
 Table 48. Johnson and Johnson Business Overview
 Table 49. Johnson and Johnson Orally Disintegrating Drug Product
 Table 50. Johnson and Johnson Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 51. Johnson and Johnson Recent Development
 Table 52. GSK Company Details
 Table 53. GSK Business Overview
 Table 54. GSK Orally Disintegrating Drug Product
 Table 55. GSK Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 56. GSK Recent Development
 Table 57. Otsuka Company Details
 Table 58. Otsuka Business Overview
 Table 59. Otsuka Orally Disintegrating Drug Product
 Table 60. Otsuka Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 61. Otsuka Recent Development
 Table 62. Vartris Company Details
 Table 63. Vartris Business Overview
 Table 64. Vartris Orally Disintegrating Drug Product
 Table 65. Vartris Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 66. Vartris Recent Development
 Table 67. Teva Company Details
 Table 68. Teva Business Overview
 Table 69. Teva Orally Disintegrating Drug Product
 Table 70. Teva Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 71. Teva Recent Development
 Table 72. Pfizer Company Details
 Table 73. Pfizer Business Overview
 Table 74. Pfizer Orally Disintegrating Drug Product
 Table 75. Pfizer Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 76. Pfizer Recent Development
 Table 77. Eli Lilly and Company Company Details
 Table 78. Eli Lilly and Company Business Overview
 Table 79. Eli Lilly and Company Orally Disintegrating Drug Product
 Table 80. Eli Lilly and Company Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 81. Eli Lilly and Company Recent Development
 Table 82. Merck Company Details
 Table 83. Merck Business Overview
 Table 84. Merck Orally Disintegrating Drug Product
 Table 85. Merck Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 86. Merck Recent Development
 Table 87. Eisai Company Details
 Table 88. Eisai Business Overview
 Table 89. Eisai Orally Disintegrating Drug Product
 Table 90. Eisai Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 91. Eisai Recent Development
 Table 92. AstraZeneca Company Details
 Table 93. AstraZeneca Business Overview
 Table 94. AstraZeneca Orally Disintegrating Drug Product
 Table 95. AstraZeneca Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 96. AstraZeneca Recent Development
 Table 97. Bristol-Myers Squibb Company Details
 Table 98. Bristol-Myers Squibb Business Overview
 Table 99. Bristol-Myers Squibb Orally Disintegrating Drug Product
 Table 100. Bristol-Myers Squibb Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 101. Bristol-Myers Squibb Recent Development
 Table 102. Conquer Company Details
 Table 103. Conquer Business Overview
 Table 104. Conquer Orally Disintegrating Drug Product
 Table 105. Conquer Revenue in Orally Disintegrating Drug Business (2020-2025) & (US$ Million)
 Table 106. Conquer Recent Development
 Table 107. Research Programs/Design for This Report
 Table 108. Key Data Information from Secondary Sources
 Table 109. Key Data Information from Primary Sources
 Table 110. Authors List of This Report


List of Figures
 Figure 1. Orally Disintegrating Drug Picture
 Figure 2. Global Orally Disintegrating Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Orally Disintegrating Drug Market Share by Type: 2024 VS 2031
 Figure 4. Anti-Psychotics Drug Features
 Figure 5. Anti-Epileptics Drug Features
 Figure 6. Other Features
 Figure 7. Global Orally Disintegrating Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Orally Disintegrating Drug Market Share by Application: 2024 VS 2031
 Figure 9. CNS Diseases Case Studies
 Figure 10. Gastrointestinal Diseases Case Studies
 Figure 11. CVS Diseases Case Studies
 Figure 12. Other Case Studies
 Figure 13. Orally Disintegrating Drug Report Years Considered
 Figure 14. Global Orally Disintegrating Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Orally Disintegrating Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Orally Disintegrating Drug Market Share by Region: 2024 VS 2031
 Figure 17. Global Orally Disintegrating Drug Market Share by Players in 2024
 Figure 18. Global Top Orally Disintegrating Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Drug as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Orally Disintegrating Drug Revenue in 2024
 Figure 20. North America Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Orally Disintegrating Drug Market Share by Country (2020-2031)
 Figure 22. United States Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Orally Disintegrating Drug Market Share by Country (2020-2031)
 Figure 26. Germany Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Orally Disintegrating Drug Market Share by Region (2020-2031)
 Figure 34. China Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Orally Disintegrating Drug Market Share by Country (2020-2031)
 Figure 42. Mexico Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Orally Disintegrating Drug Market Share by Country (2020-2031)
 Figure 46. Turkey Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Orally Disintegrating Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Johnson and Johnson Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 50. GSK Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 51. Otsuka Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 52. Vartris Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 53. Teva Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 54. Pfizer Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 55. Eli Lilly and Company Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 56. Merck Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 57. Eisai Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 58. AstraZeneca Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 60. Conquer Revenue Growth Rate in Orally Disintegrating Drug Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Orally Disintegrating Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orally Disintegrating Tablets Market Research Report 2024
Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030
Orally Dissolving Tablets ODT Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mouth dissolving Tablets Market Insights Forecast to 2030
Global Fast disintegrating Tablets Market Insights Forecast to 2030
Global Rapid dissolving Tablets Market Insights Forecast to 2030
Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024
Global Fast dissolving Tablets Market Insights Forecast to 2030
Global Orally Disintegrating Tablet Technology Market Research Report 2024
Global Orodispersible Tablets Market Insights Forecast to 2030
Global Excipients for Orally Disintegrating Tablets ODT Market Research Report 2024
Global Oral Disintegrating Strips Market Research Report 2024
Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024
Global Oral Solid Dosage Medicine Market Research Report 2025
Global Oral Fast Dissolving Film OFDF Market Research Report 2024
Global Orodispersible Film Market Research Report 2025
Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025
Global Fast Melt Tablet Market Research Report 2024
Global Orally Disintegrating Films ODFs Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions